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Drug misuse should always be considered in young people with impaired 
consciousness 
Abstract 
We agree with Ikeda et al that the absence of systolic hypertension may provide some discriminatory 
power towards exclusion of brain lesions, be they ischaemic, haemorrhagic, or space occupying in 
nature.1 However, we disagree with them that neurological examination of patients with impaired 
consciousness is often a waste of time and resources and can delay diagnosis. 
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Indiscriminate investigations have adverse effects
Editor—The application of evidence based
medicine is leading to better treatments by
thorough evaluation of treatments based on
analyses of risks and benefits. These balance
the beneficial clinical gains against the
adverse pharmacological and medical
effects, using information derived from ran-
domised controlled trials and cost effective-
ness studies. In contrast, no such critical
approach has been taken for diagnostic tests
nor have the consequences and adverse
effects of inappropriate investigations been
explored. The debate around diagnostic
tests has centred largely on minimising the
unit costs of the delivery of tests in the light
of the enormous increase in the demand for
investigations without an obvious and
proportionate improvement in health sta-
tus.1
The case report by Krishnan et al
highlights an adverse effect of an inappro-
priate investigation in a woman with
hypothyroid induced ascites.2 The published
literature is clear that ascites, and any serous
effusion of any aetiology, is associated with
raised CA125 concentration.3 Yet despite
this evidence, the interpretation of a false
positive result triggered a number of adverse
effects and consequences—namely, a clinical
consultation by an oncologist, computed
tomography of the abdomen, diagnostic
laparoscopy, mammography, and oral gas-
troduodenoscopy. These inappropriate sec-
ondary investigations carry considerable
physical, emotional, and financial cost.
What can we do to improve the
appropriate use of laboratory and radiologi-
cal investigations? Previous attempts at edu-
cating clinical staff have shown only short
lived improvements.4 We need better solu-
tions because there is a vicious amplification
cycle in which increases in investigations are
mirrored by increases in operative proce-
dures,5 justified on the basis of the investiga-
tions which themselves generate investiga-
tions. This increase in test volume increases
the probability of error and harm to
patients. The discipline of evidence based
diagnostics may not exist because we do not
know what questions to ask in relation to
investigation strategies or because there are
no hard end points (such as death or cure) to
judge success as in pharmacological studies.
That should not be an excuse to ignore a
significant problem. Where the definition of
a disease is made by laboratory and
radiological investigations, it is mandatory
that the error rate and interferences in the
tests are recognised.
Julian H Barth consultant in chemical pathology and
metabolic medicine
j.h.barth@leeds.ac.uk
Richard G Jones senior lecturer and honorary
consultant in chemical pathology
Department of Clinical Biochemistry and
Immunology, Leeds Teaching Hospitals NHS Trust,
Leeds General Infirmary, Leeds LS1 3EX
1 Winkens R, Dinant G-J. Rational, cost effective use of
investigations in clinical practice. BMJ 2002;321:783-5.
2 Krishnan STM, Philipose Z, Rayman G. Hypothyroidism
mimicking intra-abdominal malignancy. BMJ
2002;325:946-7.
3 Ferrer J, Villarino MA, Encabo G, Felip E, Bermejo B, Vila
S, et al. Diagnostic utility of CYFRA 21-1, carcinoembry-
onic antigen, CA 125, neuron specific enolase, and
squamous cell antigen level determinations in the serum
and pleural fluid of patients with pleural effusions. Cancer
1999;86:1488-95.
4 Fraser CG, Woodford FP. Strategies to modify the
test-requesting patterns of clinicians. Ann Clin Biochem
1987;24:223-31.
5 Verrilli D, Welch HG. The impact of diagnostic testing on
therapeutic interventions. J Am Med Assoc 1996;275:
1197-8.
Simple presentation of test
accuracy may lead to inflated
disease probabilities
Editor—We found that conveying infor-
mation on the accuracy of tests in non-
technical language improved doctors’ ability
to estimate disease probabilities accurately.1
We investigated whether doctors might mis-
use such non-technical presentation when
considering the probability of endometrial
cancer in a patient with positive results on
transvaginal ultrasonography.
We presented 263 general practitioners
in Switzerland with a pre-test probability of
10%, information that the patient was aged
65, and a positive transvaginal ultrasound
result. Ninety two general practitioners
(group 1) received no information on the
test’s accuracy; 92 (group 2) were told that
the sensitivity of the test was 80% and
specificity 60%; and 79 (group 3) were told
that a positive result is obtained twice as fre-
quently in women with endometrial cancer
as in those without the disease, reflecting a
likelihood ratio of 2. The last two statements
are numerically equivalent since the likeli-
hood ratio equals sensitivity/(1–specificity).
The table shows that the degree of over-
estimation of diagnostic accuracy varied
with the presentational format. As we found
previously,1 almost half of the doctors did
not change their probability estimates after
they were provided with the patient’s age.
We also found that the non-technical
format resulted in 25 of the 79 general prac-
titioners in group 3 (32% (95% confidence
interval 22% to 43%)) multiplying their pre-
test probability by exactly 2. This is theoreti-
cally incorrect since, for example, a likeli-
hood ratio of 2 changes a pre-test
probability of 40% to 57% only, not to 80%,
which requires a likelihood ratio of 6. Unfor-
tunately, in our study, this mistake helped
those respondents who did not change their
pre-test probability after being given the
patient’s age to get close to the correct value,
Distributions of attributed likelihood ratios in three groups given different summaries of information on
diagnostic accuracy
Group
Median attributed likelihood ratio
(25th centile, 75th centile) Comparison between groups P value*
Original analysis
1 (n=92) 9 (3, 69) 1 v 2 0.0193
2 (n=92) 6 (2, 22) 1 v 3 0.0003
3 (n=79) 3 (2, 9) 2 v 3 0.2284
1 v (2+3) 0.0006
All 0.0013
Stricter analysis
1 (n=92) 9 (3, 69) 1 v 2 0.0193
2 (n=92) 6 (2, 22) 1 v 3 0.1636
3 (n=54) 9 (3, 17) 2 v 3 0.5682
1 v (2+3) 0.0216
All 0.0599
*Kruskal-Wallis test.
Formula to convert pre-test probability (P1) into post-test probability (P2):
Pre-test odds×likelihood ratio=post-test odds, where pre-test odds=P1/(1−P1) and P2=post-test odds/(1+post-test odds).
Group 1 received no information on the test’s accuracy; group 2 were told that the sensitivity of the test was 80% and
specificity 60%; group 3 were told that a positive result is obtained twice as frequently in women with endometrial cancer as
those without the disease.
Actual likelihood ratio associated with the test result was 2.25.
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changing 10% into 20%, corresponding to
an attributed likelihood ratio of 2.25.
The table also shows the results after
omission of these 25 doctors. The provision
of some form of quantitative information
still seems advantageous (contrast group 1 v
groups 2 and 3; P=0.0216). However, all
comparisons including group 3 are affected
by this stricter analysis.
Framing the diagnostic information in
the user friendly way that we used for the
likelihood ratio may invite doctors to use
simple arithmetic and might lead to grossly
inflated inferences when pre-test probabili-
ties are high or likelihood ratios are larger.
Lucas M Bachmann research fellow
lucas.bachmann@evimed.ch
Johann Steurer director
Horten Centre, Zurich University, PO Box Nord,
CH-8091 Zurich, Switzerland
Gerben ter Riet senior research fellow
Department of General Practice, Academic Medical
Centre, University of Amsterdam, Room J3-354,
Meibergdreef 15, NL-1105 AZ Amsterdam,
Netherlands
1 Steurer J, Fischer JE, Bachmann LM, Koller M, ter Riet G.
Communicating accuracy of tests to general practitioners:
a controlled study. BMJ 2002;324:824-6.
Effect of computerised
evidence based guidelines
Computer support is complex
intervention
Editor—Eccles et al’s rigorous approach to
the evaluation of a computerised decision
support system for the management of
angina and asthma accounted for many of
the flaws in previous trials of computer sup-
port.1 They were no doubt disappointed that
no effect was seen, probably due to low
usage of the system.
Although not discussed in the paper, a
possible explanation for this is that, given
the comparatively high use of computers
required for inclusion in the trial, the
practices already used simpler computerised
templates to promote collection of process
of care data. Practitioners may therefore
have perceived little further to be gained by
using the more detailed decision support
system, particularly if it did not allow easy
switching between the guideline and the
clinical system.
The study by Eccles et al shows the com-
plexity of interventions in primary care that
incorporate computerised decision support
systems. This complexity needs to be fully
accounted for in designing and evaluating
such interventions.2 Even with an apparently
well developed piece of software, the trial
assumed that offering brief training to a
minority of practitioners in each practice
would be sufficient for it to be incorporated
into the increasingly complex care provided
in routine general practice consultations.
Trials of computer support in primary
care need to acknowledge this complexity by
embedding use of the software in a carefully
specified model of care. For the high quality
management of chronic disease, this model
will probably require subspecialisation
within a general practice, as proposed in the
new general practitioner contract.3
Providing focused training to key people
in a practice and supporting subspecialisa-
tion through computer decision support
may be a more appropriate approach to
chronic disease management in primary
care. Future trials of computer support must
consider not only the technical features of
the software but also the model of service it
is supporting and hence the training
requirements of potential users. Theoreti-
cally derived measures that predict use of
the software by practitioners in these trials
could provide further important data on the
potential role of decision support in clinical
practice. Only then can one truly give
computer decision support a fair trial.
Jon D Emery Cancer Research UK clinician scientist
Department of Public Health and Primary Care,
University of Cambridge, Institute of Public Health,
Cambridge CB2 2SR
jde10@medschl.cam.ac.uk
Competing interests: None declared.
1 Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J,
Parkin D, et al. Effect of computerised evidence based
guidelines on management of asthma and angina in adults
in primary care: cluster randomised controlled trial. BMJ
2002;325:941-4. (26 October.)
2 Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sand-
ercock P, Spiegelhalter D, et al. Framework for design and
evaluation of complex interventions to improve health.
BMJ 2000;321:694-6.
3 Marshall M, Roland M. The new contract: renaissance or
requiem for general practice? Br J Gen Pract
2002;52:531-2.
Challenge should not be abandoned
Editor—As a coauthor of the trial of
COGENT, a clinical decision support sys-
tem, I would like to correct any misunder-
standing this paper may have caused.1 2 I
head a large centre for health informatics in
the United Kingdom and lead the develop-
ment of the Prodigy clinical decision
support system.
The COGENT trial of two computerised
guidelines found no differences in a range of
measures of the process and outcomes of
care, primarily because the system was not
used. But these findings should not be
extrapolated to other decision support
systems.
Readers to whom I have talked have
assumed that COGENT guidance and
software was based on the current Prodigy
system. COGENT used evidence based
guidelines from the north of England on the
management of asthma and angina and
software based on ideas from early Prodigy
software. Constraints in the COGENT trial
did not allow the software to be tested in
practice before the intervention period or
the guidance to be reworded for easier com-
prehension. Major shortcomings were soon
apparent, but these problems could not be
addressed because the trial method did not
accommodate the usual process of software
development and guidance formatting. With
hindsight, a randomised controlled trial of a
new technology (such as a clinical decision
support system) should not be have been
undertaken until the technology had been
shown to be usable and to be regularly used.3
Which way forward? In an increasingly
complex world, clinicians overloaded with
information need computerised decision
support systems if their practice is to be evi-
dence based. The challenge of developing
and integrating such systems into clinical
workflow should not be abandoned. Not to
invest in such systems would be as inappro-
priate as suggesting that the British army
should give up its rifles because of their cur-
rent technical problems.
Ian N Purves professor of health informatics
Sowerby Centre for Health Informatics at
Newcastle, University of Newcastle on Tyne,
Newcastle on Tyne NE2 4AB
ian.purves@ncl.ac.uk
Competing interests: INP is a grant holder,
Prodigy contract (Department of Health).
1 Eccles M, Grimshaw J, Steen N, Parkin D, Purves I, McColl
E, et al. The design and analysis of a randomised control-
led trial to evaluate computerised decision support in pri-
mary care: the COGENT Study. Fam Pract 2000;17: 180-6.
2 Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J,
Parkin D, et al. Effect of computerised evidence based
guidelines on management of asthma and angina in adults
in primary care: cluster randomised controlled trial. BMJ
2002;325:941-4. (26 October.)
3 Heathfield H, Pitty D, Hanka R. Evaluating information
technology in health care: barriers and challenges. BMJ
1998;316:1959-61.
It is good to be honest and say that
systems were not used
Editor—The paper by Eccles et al possesses
academic integrity, which is widely lacking in
computing research.1
I was the main researcher for the first
two phases of the Prodigy project and
believe that this project has much to teach
the Prodigy team. One of the first detailed
reports I wrote on Prodigy in 1998 indicated
that Prodigy was actually used very little,
about seven times a week, and most of the
time (88%) users requested to bypass the
system (www.robinbt2.free-online.co.uk/
virtualclassroom/chap13/report1.pdf). I am
very heartened to see that this type of infor-
mation is being disseminated rather than
suppressed, as was the case with the report I
produced.
Robin Beaumont independent health informatics
consultant
Faculty of Medical Informatics, Royal College of
Surgeons of Edinburgh, Edinburgh EH8 9DW
robin@ieg-net.co.uk
Competing interests: None declared.
1 Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J,
Parkin D, et al. Effect of computerised evidence based
guidelines on management of asthma and angina in adults
in primary care: cluster randomised controlled trial. BMJ
2002;325:941-4. (26 October.)
Opportunity was missed
Editor—Eccles et al performed a methodo-
logically sound study of a poorly developed
intervention.1 They define a computerised
support system as a system that compares
patients’ characteristics with a knowledge
base and then guides a health provider by
offering patient specific and situation spe-
cific advice.1
The intervention developed and tested
in their study does not seem to meet these
Letters
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criteria. It did not depend on patient specific
information but entry of a more general
Read code. It did not contain a reminder to
initiate review of patient care or arrange fol-
low up. How far treatment recommenda-
tions depended on the patient’s individual
clinical review rather than issuing more
generic recommendations for treatment is
also unclear.2 3
The Prodigy system, the intervention
around which this study was based, is an
electronic version of a paper guideline that
is triggered by entry of a prespecified Read
code. By making this the only way in which
to enter the computerised guideline the
investigators ensured a low level of use dur-
ing the study. General practitioners are
unlikely to continue to enter the same Read
code at every consultation as it would mean
that each participating patient would have
multiple duplicate entries of the same Read
code in their electronic record.
By excluding any sort of reminder func-
tion in their system,2 the investigators have
not accounted for a barrier in managing
chronic diseases—registration, recall, and
regular review of patients. Analysis of factors
that operate in managing angina and
asthma should have uncovered such barriers
before the start of this study.4
Other details about the use of the
computerised guideline require clarification.
What is the definitive number of patients
randomised and followed up in each
practice for each intervention? What is the
number (percentage) of patients in whom
the computer guideline went past the first
screen? What is the number (percentage) for
whom a complete record entry was made?
The authors make no comment on the
differential use of the electronic guidelines
between the two computer suppliers.
This study reinforces the fact that
passive diffusion of guidelines, in electronic
or paper format, is an ineffective way to
implement best practice.4 Paying insufficient
attention to how a computer interface oper-
ates has produced low levels of usage and
made the evaluation less useful than it might
have been.2 5 Future studies should take into
account the different functions of computer
based clinical decision support systems,5
rather than simply generate suggestions to
alter prescribing practice.2
Tom Fahey professor of primary care medicine
t.p.fahey@dundee.ac.uk
Liz Mitchell lecturer
Frank Sullivan professor of research and development
in primary care
Tayside Centre of General Practice, University of
Dundee, Dundee DD2 4AD
Alan Montgomery lecturer in primary care health
services research
Division of Primary Health Care, University of
Bristol, Bristol BS6 6JL
Peter Gregor senior lecturer in applied computing
Department of Applied Computing, University of
Dundee, Dundee DD1 4HN
Competing interests: None declared.
1 Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J,
Parkin D, et al. Effect of computerised evidence based
guidelines on management of asthma and angina in adults
in primary care: cluster randomised controlled trial. BMJ
2002;325:941-4. (26 October.)
2 Randolph A, Haynes RB, Wyatt JC, Cook DJ, Guyatt GH.
Users’ guides to the medical literature. XVIII. How to use an
article evaluating the clinical impact of a computer-based
clinical decision support system. JAMA 1999;282:67-74.
3 Hunt D, Haynes RB, Hanna S, Smith K. Effects of
computer-based clinical decision support systems on phy-
sician performance and patient outcomes. JAMA
1998;280:1339-46.
4 Anonymous. Getting evidence into practice. Effect Health
Care Bull 1999;5:1-16.
5 Tai S, Nazareth I, Donegan C, Haines A. Evaluation of gen-
eral practice computer templates: lessons from a pilot ran-
domized controlled trial. Methods Inf Med 1999;38:177-81.
Effect may be function of incentive
Editor—In their paper Grimshaw et al
showed that having guidelines available
does not result in people using them.1
Analogously, Eccles et al showed that having
a decision support system available does not
lead to people using it.2 Benson advocated
incentives are needed before healthcare
workers start using computers.3
In contrast to Eccles et al, van Wijk et al
showed effects from a guideline decision
support system.4 5 The general practitioners
in these studies had incentives to use the
tool, whereas such incentives were missing
in Eccles et al’s design. We believe that
authors of papers describing an evaluation
of a decision support system should in the
future explicitly discuss incentives for and
barriers to using these systems.
Jacobus T van Wyk research fellow
Peter W Moorman assistant professor
Marc A M van Wijk assistant professor
Department of Medical Informatics, Erasmus MC,
University Medical Centre Rotterdam, PO Box
1738, NL-3000 DR Rotterdam, Netherlands
1 Grimshaw J, Russell I. Effect of clinical guidelines on medi-
cal practice: a systematic review of rigorous evaluations.
Lancet 1993; 342:1317-22.
2 Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J,
Parkin D, et al. Effect of computerised evidence based
guidelines on management of asthma and angina in adults
in primary care: cluster randomised controlled trial. BMJ
2002;325:941-4. (26 October.)
3 Benson T. Why general practitioners use computers and
hospital doctors do not—part 2: scalability. BMJ
2002;325:1090-3.
4 van Wijk MA, van der Lei J, Mosseveld M, Bohnen AM, van
Bemmel JH. Assessment of decision support for blood test
ordering in primary care. A randomized trial. Ann Intern
Med 2001;134:274-81.
5 van Wijk MA, der Lei J, Mosseveld M, Bohnen AM, van
Bemmel JH. Compliance of general practitioners with a
guideline-based decision support system for ordering
blood tests. Clin Chem 2002;48:55-60.
Authors’ reply
Editor—We agree that complex interven-
tions should ideally be developed through an
iterative process.1 Exceptions to this include
evaluating a preformed intervention that
would not otherwise be rigorously evaluated.
This applied at the outset of our study,
although our intervention drew heavily on
the iterative development of Prodigy soft-
ware. We conducted an integrated process
evaluation to understand the results better.
This will appear in the BMJ shortly.
The NHS has invested large amounts of
money in information technology, some-
times for little or no benefit. The evaluation
of information technology is complex and
multifaceted, but a computerised decision
support system can be evaluated as a health
technology. Although formative evaluation
may be an important element of software
development, until someone comes up with
better methods of producing unbiased
estimates of effectiveness and efficiency we
maintain that all health technologies should
be considered evaluable in randomised con-
trolled trials.
Important methodological issues exist
about the timing and duration of such
evaluations, and we agree with Purves that
they should be performed on stable systems.
Given the cyclical nature of software
development and the self belief and enthusi-
asm of developers, such points must be pre-
specified and enacted to avoid self perpetu-
ating iterative cycles of development with
the constant promise of jam tomorrow.
Our description of the system that we
evaluated is accurate, and none of the
authors dissented from it up to the point of
publication.
Data were collected from November
1997 to September 2000, with the interven-
tion running during the last 15 months of
this time period. The trial was paused for six
months while the software team worked on
improvements. The rates of presentation of
patients we reported equated to opportuni-
ties for the system to be used between twice
a day and every other day. Moreover, by the
start of the intervention period, Prodigy
software had become available and was
delivered to trial practices alongside the
study software. Our feedback from practices
indicated that at least some asked for the
Prodigy software to be turned off. This ech-
oes Beaumont’s letter and implies that
increasing the number of guidelines offered
may not be the remedy that Purves suggests.
Two correspondents identified the
importance of the issue of training. Contrary
to Purves’s letter, two people from each prac-
tice were invited to a one day training session
and the software was installed within 10
weeks by the computer supplier of two thirds
of the trial practices. For the second supplier
this interval was almost double, owing to
unforeseeable commercial considerations in
the company. We acknowledged the import-
ance of training while suggesting that what
happened was representative of the real
world of primary care. We still believe this to
be true but support Emery’s and Purves’s call
for better training in service settings.
Fahey et al say that the low levels of use
of the system were partly due to requiring
the entry of a single Read code and lack of
responsiveness to patient specific infor-
mation. Initially the system could be
triggered automatically by a range of
specified Read codes in the patient record. It
could also be triggered by a clinician
entering Read codes selected by the practice
and was therefore not a passive method of
dissemination. But this was changed in
response to requests from the study
practices. The automatic triggering was
removed and a customisable Read code
entry method was used for the final eight
months of the intervention. Thus the system
did rely on patient specific information.
Emery said that we may have had a ceil-
ing effect due to practices currently using
computerised templates. This seems unlikely
because only 26% of practices already had
Letters
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computerised guidelines or protocols for
angina and 46% for asthma.
Within Emery’s suggestion of specified
models of care we see the risk that clinicians
and patients in primary care will be
constrained to consult in ways that comput-
ers can cope with, rather than addressing the
challenge of the integration of computers
into patient centered consultations.
Martin P Eccles professor of clinical effectiveness
martin.eccles@ncl.ac.uk
Elaine McColl national primary care career scientist
Nick Steen statistician
Nikki Rousseau research associate
Centre for Health Services Research, University of
Newcastle upon Tyne, Newcastle upon Tyne
NE2 4AA
Jeremy Grimshaw professor
Health Services Research Unit, University of
Aberdeen, Aberdeen AB25 2ZD
David Parkin professor of health economics
Department of Economics, City University, London
EC1V 0HB
Competing interests: None declared.
1 Medical Research Council. A framework for development and
evaluation of RCTs for complex interventions to improve health.
London: MRC, 2000.
Novartis was not in breach of
code for “inventing” disease
Editor—Ferriman’s news item is incorrect
on at least two counts.1
Firstly, it is not true to state that the
authority had imposed no penalty on the
company for issuing misleading literature.
Novartis, like all companies ruled in breach
of the Association of the British Pharmaceu-
tical Industry’s code of practice for the phar-
maceutical industry, had to undertake that
the use of all relevant material and activity
would cease forthwith and that it would take
all possible steps to avoid a similar breach of
the code in the future.
Novartis voluntarily withdrew the mate-
rial before the Prescription Medicines Code
of Practice Authority had been notified of Dr
Robert Flowerdew’s concerns and well in
advance of Novartis being required by the
authority to withdraw all relevant material.
Four times a year the authority publishes
detailed case reports in the Code of Practice
Review. The review is widely circulated by the
authority and is available on request. There
is also some secondary publication of the
reports. Publicity is seen as a major sanction.
I anticipate that the report on this case will
be published in this month’s edition of the
Code of Practice Review.
Secondly, the impression from the head-
ing to the article, as above, is misleading.
Novartis was not ruled in breach of the code
for inventing a disease. Novartis was ruled in
breach of the code for giving a misleading
impression of the effect of Starlix on cardio-
vascular mortality and risk as detailed in the
main body of the article.
Heather Simmonds director
Prescription Medicines Code of Practice Authority,
London SW1YA 2DY
1 Ferriman A. Novartis breached code after doctors say it
“invented” a disease. BMJ 2002;325:1379. (14 December.)
Assortative mating may explain
spouses’ risk of same disease
Editor—Hippisley-Cox et al observed sig-
nificant similarities for disease between
spouses in a large sample of 8386 couples
recruited through general practice.1 They
think that shared environmental factors may
cause these similarities but reject assortative
mating as an explanation.
In a sample from the Netherlands twin
register we could not replicate their spouse
similarities for asthma, depression, diabetes,
and cardiovascular disease, possibly because
of our smaller sample size of 2152 spouse
pairs.2 When we examined health behaviour
in a larger sample we found good associa-
tions between spouses for smoking, alcohol
problems, and exercise behaviour, even after
controlling for age and body mass index of
both spouses.
The duration of the relationship influ-
enced these associations between spouses
(figure). Except for alcohol problems, spouse
similarities in health behaviour decreased as
the duration of the relationship increased.
This implies that assortment for these
factors is based on similarity at the time dat-
ing began3 and highlights the importance of
determining similarities in disease status at
the time of dating, as suggested by
Hippisley-Cox et al.
Assortative mating may further be based
on social factors and personality traits. In our
sample we found significant correlations
between spouses for educational attainment,
an indicator of socioeconomic status, which is
also related to disease development. These
correlations increased as the duration of the
relationship increased (r=0.292, r=0.356,
r=0.587 for < 5 years, >5 years, and > 15
years, respectively), possibly owing to conver-
gence of phenotypes of the spouses or to a
higher divorce rate in dissimilar pairs.3
Significant correlations between spouses
were also found for inhibition, a personality
trait associated with increased risk behaviour,
but these correlations were unaffected by the
duration of the relationship (r=0.386, r=0.334,
r=0.373 for < 5 years, >5 years, and > 15
years, respectively).
These results show that different mechan-
isms underlie similarities between spouses for
health behaviour, social factors, and person-
ality traits. The fact that similarities between
spouses were found for this wide range of
variables indicates, however, that assortative
mating should not be hastily dismissed as a
cause for spouse similarities in disease.
Any association between spouses does
not exclude genetic effects. Hippisley-Cox et
al assume that because spouses are unrelated,
genes do not influence the association. But
the similarity of spouses may be an example
of an active genotype-environment correla-
tion which occurs when a particular genotype
is associated with the selection or creation of
a particular environmental circumstance.4
Gonneke Willemsen lecturer, epidemiology
ahm.willemsen@psy.vu.nl
Jacqueline M Vink researcher, genetic epidemiology
Dorret I Boomsma professor, genetic epidemiology
Department of Biological Psychology, Vrije
Universiteit, NL-1081 BT Amsterdam, Netherlands
1 Hippisley-Cox J, Coupland C, Pringle M, Crown N,
Hammersley V. Married couples’ risk of same disease:
Cross sectional study. BMJ 2002;325:1-5. (21 September.)
2 Boomsma DI, Vink JM, van Beijsterveldt CEM, de Geus
EJC, Beem AL, Mulder EJCM, et al. Netherlands twin reg-
ister: a focus on longitudinal research. Twin Res (in press).
3 Price RA, Vandenberg SG. Spouse similarity in American
and Swedish couples. Behav Genet 1980;10:59-71.
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Drug misuse should always be
considered in young people
with impaired consciousness
Editor—We agree with Ikeda et al that the
absence of systolic hypertension may provide
some discriminatory power towards exclu-
sion of brain lesions, be they ischaemic,
haemorrhagic, or space occupying in nature.1
However, we disagree with them that neuro-
logical examination of patients with impaired
consciousness is often a waste of time and
resources and can delay diagnosis.
Although hypertension may be an
important potential marker, a careful neuro-
logical examination of the papillary
response, reflexes, and funduscopy is an
important part of the assessment of any
patient with impaired consciousness.2
Furthermore, we would like to raise con-
cern over the idea that impaired conscious-
ness in conjunction with systolic hyper-
tension implies that a brain lesion is present.
This may be true for older people (the mean
age in the Ikeda study was 65 years), but in
our experience, impaired consciousness
with systolic hypertension in younger
people ( < 30 years) implies ingestion of
sympathomimetic drugs—for example,
ecstasy, amphetamine, cocaine.3 4
Hypertension secondary to ingestion of
sympathomimetic drugs requires urgent
correction (usually with intravenous nitrates)
to prevent secondary complications such as
intracerebral haemorrhage, renal failure,
Odds of smoking (current smoking and ever
smoked), participating in exercise (sport and
cycling), and alcohol problems in women whose
partner had the same lifestyle compared with women
whose partner did not. Logistic regression analyses
were adjusted for age and body mass index of both
men and women
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and myocardial ischaemia3–5; if, as is said by
Ikeda et al, the hypertension and impaired
consciousness are assumed to be related to a
brain lesion, the delays in obtaining imaging
investigations could lead to delays in
instituting potentially life saving treatment.
The possibility of illicit drug ingestion
should be considered in any young, hyper-
tensive patient presenting to an emergency
department with reduced consciousness, so
that appropriate management can be
started without delay.
Kim Whelan registrar in toxicology
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Alison Jones consultant physician
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Unit of analysis errors should
be clarified in meta-analyses
Editor—Weingarten et al present a com-
prehensive study in what is a complex area
of research.1 We were, however, unclear
whether any of the included primary studies
had unit of analysis errors and how the
authors dealt with such studies in their
meta-analysis.
Unit of analysis errors occur in cluster
randomised trials when individual patients’
data are analysed as if there was no clustering
in the provider, practice, or units randomised
to the intervention groups (patients’ data are
analysed as independent observations).2
Standard statistical methods that do not
account for cluster effects in cluster ran-
domised trial data result in the overestima-
tion of the significance of an intervention
(artificially extreme P values and overly
narrow confidence intervals).2 Correspond-
ingly, the inclusion of studies with unit of
analysis errors in a meta-analysis will give
greater weight to the results of such studies.3
The table of included studies reported by
Weingarten et al indicated that the unit of
analysis differed from the unit of random-
isation in 22 cluster randomised trials, but it
was not clear from the report how often unit
of analysis errors occurred in these studies or
how the authors dealt with studies with such
errors in the meta-analysis. Methods exist for
re-analysing studies with such errors.
We recently completed a systematic
review of guideline dissemination and
implementation strategies; 51 out of 110
cluster randomised trials had unit of analysis
errors, and reanalysis was possible in only
one study. Poor reporting of cluster ran-
domised trials has led to a proposed
extension to the CONSORT statement,
which is currently under discussion.4 Sys-
tematic reviews of studies with unit of analy-
sis errors should clearly state how they
handled such studies in a review.
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GPs can separate oncological
wheat from chaff
Editor—Summerton’s editorial on the
problem of identifying symptoms poten-
tially indicating an underlying cancer in pri-
mary care calls for research based theory.1
Only community based studies will help
general practitioners to decide on the
importance of a symptom or physical sign
reported by their patients as hospital series
are unrepresentative.
Although selection bias is part of the
problem, it may be comparatively minor as
most patients with cancer are treated in sec-
ondary care, even though their disease is
diagnosed in primary care. Perhaps more
important is bias from the development of
symptoms in the time from the first
symptom appearing to presentation in
primary care and finally hospital.
General practitioners are already quite
successful in sifting out the wheat from the
chaff (although the comparative rarity of
cancer in primary care indicates that a better
farming analogy would be finding a needle
in the haystack). For example, an estimated
positive predictive value for colorectal
cancer of rectal bleeding in the community
is 0.1%.2 3 Once it is reported to the doctor
this rises to 2-3%,3 4 and in patients referred
for investigation it is 5.2%.5
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Look before you flush
Editor—Moayyedi and Ford described
recent advances in gastroenterology.1 The
national programme for early detection of
colon cancer uses the following statement to
raise public awareness for early detection of
rectal bleeding: “Look at it before you
flush it.”
It is really helpful to make people
aware of looking for early signs of colon
cancer, but I have noticed some important
things that might hinder this national
programme.
The lavatory disinfectants now sold in
supermarkets are mostly blue in colour
and change water blue, which makes
looking for any blood quite difficult. I
suggest that we stop selling colouring
agents and replace them by colourless ones
or even use reagents that turn a certain col-
our in the presence of minor blood
amounts. Can we?
Mourad Ibrahim Habib clinical research fellow
St James’s University Hospitals, Leeds LS9 7 TF
mouradhabib@hotmail.com
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Correction
Open letter to Tony Blair: Call to prevent
escalating violence
An editorial error occurred in this open letter
to Tony Blair (p 220, 25 January). By adding
“the” to the authorship line we implied that
the letter had been signed by all staff,
students, and alumni of the London School of
Hygiene and Tropical Medicine. The author-
ship line should have read: “On behalf of 500
staff, students, and alumni of the London
School of Hygiene and Tropical Medicine,
and in collaboration with Medact” [not “On
behalf of the staff, students, and alumni . . .” as
published].
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